Assessment of cardiac autonomic modulation during adolescent obesity

Obesity Research

Volumn 11, Issue 4, 2003, Pages 541-548

  Rabbia, Franco ^a,d   Silke, Bernard ^c   Conterno, Andrea ^a   Grosso, Tiziana ^a   De Vito, Barbara ^b   Rabbone, Ivana ^b   Chiandussi, Livio ^a   Veglio, Franco ^a  

^a Ospedale San Vito   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c ST JAMES S HOSPITAL   (Ireland)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Blood pressure; Heart rate variability; Hypertension; Pediatric obesity; Spectral analysis

Indexed keywords

TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD; BLOOD PRESSURE; BODY MASS; CHILD; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART; HEART RATE; HOMEOSTASIS; HUMAN; INNERVATION; INSULIN RESISTANCE; MALE; OBESITY; PATHOPHYSIOLOGY;

ADOLESCENT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHILD; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART RATE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; TRIGLYCERIDES;

EID: 0142155648     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.76     Document Type: Article

References (38)

1. Kannel WB. Blood pressure as cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571-6.
2. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertrygliceridemia, and hypertension. Arch Intern Med. 1989;149:1514-20.
3. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 task force report on high blood pressure in children and adolescents. Pediatrics. 1996;98: 649-58.
4. Björntorp P. Obesity. Lancet. 1997;350:423-6.
5. Dustan H. Mechanisms of hypertension associated with obesity. Ann Intern Med. 1983;98:860-4.
6. Messerli FH, Christie B, DeCarvalho JG, et al. Obesity and essential hypertension: hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med. 1981;141:81-5.
7. Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension. 1992;19(Suppl I):I67-77.
8. Esler M, Rumantir M, Weisner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens. 2001;14: 304-9S.
9. Grassi G. Debating sympathetic overactivity as a hallmark of human obesity: a pro's position. J Hypertens. 1999;17: 1059-60.
10. Rumantir MS, Vaz M, Jennings GL, et al. Neural mechanism in human obesity-related hypertension. J Hypertens. 1999;17:1125-33.
11. Verwaerde P, Sénard JM, Galinier M, et al. Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs. J Hypertens. 1999;17:1135-43.
12. Masuo K, Mikami H, Ogihara T, Tuck ML. Weight gain-induced blood pressure elevation. Hypertension. 2000;35: 1135-40.
13. Rolland-Cachera MF, Deheeger M, Bellisle F, et al. Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr. 1984;39:129-35.
14. Lansang G, Williams GH, Carroll JS. Correlation between the glucose clamp and the homeostasis model assessment in hypertension. Am J Hypertens. 2001;14:51-3.
15. Staessen JA, Bieniaszewski L, O'Brien E, Gosse P, Hayashi H, Imai Y. Nocturnal BP fall on ambulatory monitoring in a large international database. Hypertension. 1997;29:30-9.
16. Berntson GG, Quigley KS, Jang JF, Boysen ST. An approach to artifact identification: application to heart period data. Psychophysiology. 1990;27:586-98.
17. Akselrod S. Spectral analysis of fluctuations in cardiovascular parameters: a quantitative tool for the investigation of autonomic control. Trends Pharmacol Sci. 1988;9:6-9.
18. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043-65.
19. Von Neumann J, Kent RH, Bellinson HR. The mean square successive difference. Ann Math Stat. 1941;12:153-62.
20. Hnatkova K, Copie X, Staunton A, Malik M. Numeric processing of Lorenz plots of R-R intervals from long-term ECG's: comparison with the time-domain measures of heart rate variability for risk stratification after myocardial infarction. J Electrocardiography 1995;28:74-80.
21. Hanratty CG, Silke B, Riddell JG. Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods. Br J Clin Pharmacol. 1999;47:157-66.
22. Copie X, Leheuzey JY, Iliou MC, et al. Correlation between time-domain measures of heart rate variability and scatterplots in postinfarction patients. Pacing Clin Electrophysiol. 1996; 19:342-7.
23. Pousset F, Copie X, LeChat P, et al. Effects of bisoprolol on heart-rate variability in heart-failure. Am J Cardiol. 1996;77: 612-7.
24. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-83.
25. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-8.
26. SAS Institute Inc. SAS/ASSIST Software Administrator's Guide, Version 8. Cary, NC: SAS Institute, Inc.; 1999, p. 78.
27. Peterson H, Rothschild M, Weinberg C, Fell R, MacLeish K, Pfeifer M. Body fat and the activity of the autonomic nervous system. N Engl J Med. 1988;318:1077-83.
28. Piccirillo G, Vetta F, Fimognari F, et al. Power spectral analysis of heart rate variability in obese subjects: evidence of decreased cardiac sympathetic responsiveness. Int J Obes. 1996;20:825-9.
29. Hirsch J, Leibel R, Mackintosh R, Aguirre A. Heart rate variability as a measure of autonomic function during weight change in humans. Am J Physiol. 1991;261:R1418-23.
30. Landsberg L. Hyperinsulinemia: possible role in obesity-induced hypertension. Hypertension. 1992;19(Suppl 1):I61-6.
31. Landsberg L. Obesity. In: Izzo JL, Black HR, eds. Hypertension Primer: the Essentials of High Blood Pressure, Second Edition. Baltimore, MD: Williams & Wilkins; 1999.
32. Emdin M, Gastaldelli A, Muscelli E, et al. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation. 2001;103:513-9.
33. McCaffrey PM, Riddell JG, Shanks RG. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man. Br J Clin Pharmacol. 1987;24:571-80.
34. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest. 1994;93:2365-71.
35. Grekin RJ, Dumont CJ, Vollmer AP, Watts SW, Webb RC. Mechanisms in the pressor effect of hepatic portal venous fatty acid infusion. Am J Physiol. 1997;273:R324-30.
36. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100:270-8.
37. Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions Hypertension. 2002;40:441-7.
38. Mertens IL, Van Gaal LF. Overweight, obesity and blood pressure: the effects of modest weight reduction. Obes Res. 2000;8:270-8.